Abstract Listing

Abstracts Presented and Published

Monteiro, V, Chhabria S, Abbas N, Monteiro B, Wu Y, Sharma R, Amorosa L.  Risk Factors for Metabolic Syndrome in young healthy South Asians. AFMR, Southern Section, Feb 2009, New Orleans, Journ Invest. Feb 2009

X Wang, Effect of intravenous infusion of ZA on patients with primary hyperparathyroidism. 90th Endocrine Society Annual Meeting, P2-311, San Francisco, CA 2008

S Vergano, Harrison, X Wang. Type 1 polyendocrine autoimmune disease with leukemias: A case report #710, 18th Annual Mtg AACE, Houston TX 2009

E Ahn Lee, X Wang.  Case of Iodine Deficiency.in the US # 1030, 18th Annual Mtg AACE, Houston TX 2009

C Huang, X Wang:  Prevalence of PPI usage in type 2 DM patient with and without neuropathy. # 219, 18th Annual Mtg AACE, Houston TX 2009

X. Wang. SGT-2 inhibitors: A Novel Anti-diabetic Drug, the Fourth Xiangya International Diabetes Immunology Forum. Changsha, PRC 70-71, 2009

D Sukumar, N Partridge, X Wang, H Ambia-Sobhan, S Shapses  Serum monocyte chemokine protein-1 levels are positive associated with serum PTH in women.  31th ASBMR Annual Mtg, Denver, CO 2009

R McCauley, X Wang, L Amorosa.  Granulomatous hypophysitis presenting with secondary adrenal insufficiency and hypercalcemia with iodine induced hyperthyroidism.   91th Endocrine Society Annual Meeting, Washington DC 2009

D. Dadzie, S Trooskin, X Wang, Characterization of Postoperative Subclinical Primary Hyperparathyroidism and Associated Dyslipidemia. ACP national presentation, 2009.